Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl) piperazinyl) butyl]-2-naphthamide] on L-3, 4-dihydroxyphenylalanine-induced …
A Hsu, DM Togasaki, E Bezard, P Sokoloff… - … of Pharmacology and …, 2004 - ASPET
Although l-3, 4-dihydroxyphenylalanine (l-dopa) is one of the most effective therapies for
Parkinson's disease, continued treatment may result in excessive involuntary movements …
Parkinson's disease, continued treatment may result in excessive involuntary movements …
[PDF][PDF] Effect of the D3 Dopamine Receptor Partial Agonist BP897 [N-[4-(4-(2-Methoxyphenyl) piperazinyl) butyl]-2-naphthamide] on L-3, 4-Dihydroxyphenylalanine …
A Hsu, DM Togasaki, E Bezard, P Sokoloff… - THE JOURNAL OF …, 2004 - Citeseer
ABSTRACT Although L-3, 4-dihydroxyphenylalanine (L-dopa) is one of the most effective
therapies for Parkinson's disease, continued treatment may result in excessive involuntary …
therapies for Parkinson's disease, continued treatment may result in excessive involuntary …
Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl) piperazinyl) butyl]-2-naphthamide] on L-3, 4-dihydroxyphenylalanine-induced …
A Hsu, DM Togasaki, E Bezard, P Sokoloff… - The Journal of …, 2004 - europepmc.org
Although l-3, 4-dihydroxyphenylalanine (L-dopa) is one of the most effective therapies for
Parkinson's disease, continued treatment may result in excessive involuntary movements …
Parkinson's disease, continued treatment may result in excessive involuntary movements …
Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl) piperazinyl) butyl]-2-naphthamide] on L-3, 4-dihydroxyphenylalanine-induced …
A Hsu, DM Togasaki, E Bezard… - The Journal of …, 2004 - pubmed.ncbi.nlm.nih.gov
Although l-3, 4-dihydroxyphenylalanine (L-dopa) is one of the most effective therapies for
Parkinson's disease, continued treatment may result in excessive involuntary movements …
Parkinson's disease, continued treatment may result in excessive involuntary movements …
[PDF][PDF] Effect of the D3 Dopamine Receptor Partial Agonist BP897 [N-[4-(4-(2-Methoxyphenyl) piperazinyl) butyl]-2-naphthamide] on L-3, 4-Dihydroxyphenylalanine …
A Hsu, DM Togasaki, E Bezard, P Sokoloff… - THE JOURNAL OF …, 2004 - Citeseer
ABSTRACT Although L-3, 4-dihydroxyphenylalanine (L-dopa) is one of the most effective
therapies for Parkinson's disease, continued treatment may result in excessive involuntary …
therapies for Parkinson's disease, continued treatment may result in excessive involuntary …